Zobrazeno 1 - 10
of 513
pro vyhledávání: '"Jong-Young Choi"'
Publikováno v:
Journal of Pure and Applied Microbiology, Vol 15, Iss 1, Pp 164-174 (2021)
Actinobacillus pleuropneumoniae (App) and Mycoplasma hyopneumoniae (Mhp) cause porcine pleuropneumonia and mycoplasmal pneumonia, respectively, and have serious impacts on the swine industry because they retard the growth of pigs. To protect pigs aga
Externí odkaz:
https://doaj.org/article/d66b3feac23e45b9aa67ff06da886ff1
Publikováno v:
Journal of Liver Cancer, Vol 24, Iss 2, Pp 253-262 (2024)
Backgrounds/Aims Although cigarette smoking has been associated with an increased risk of hepatocellular carcinoma (HCC), its association with HCC mortality remains underexplored. We aimed to evaluate the effect of smoking on early mortality in HCC p
Externí odkaz:
https://doaj.org/article/21635f3df7b84d0c801d1295b1abf77d
Autor:
Seungchul Han, Pil Soo Sung, Soo Young Park, Jin Woong Kim, Hyun Pyo Hong, Jung-Hee Yoon, Dong Jin Chung, Joon Ho Kwon, Sanghyeok Lim, Jae Hyun Kim, Seung Kak Shin, Tae Hyung Kim, Dong Ho Lee, Jong Young Choi
Publikováno v:
Journal of Liver Cancer, Vol 24, Iss 2, Pp 131-144 (2024)
Local ablation for hepatocellular carcinoma (HCC), a non-surgical option that directly targets and destroys tumor cells, has advanced significantly since the 1990s. Therapies with different energy sources, such as radiofrequency ablation, microwave a
Externí odkaz:
https://doaj.org/article/6ab3fd584c014b8e991946fdab13205e
Autor:
Ji Won Han, Won Sohn, Gwang Hyeon Choi, Jeong Won Jang, Gi Hyeon Seo, Bo Hyun Kim, Jong Young Choi
Publikováno v:
Journal of Liver Cancer, Vol 24, Iss 2, Pp 274-285 (2024)
Backgrounds/Aims The treatment landscape for hepatocellular carcinoma (HCC) has significantly evolved over the past decade. We aimed to analyze trends in treatment patterns for HCC using a nationwide claims database from the Korean Health Insurance R
Externí odkaz:
https://doaj.org/article/fdf016e98ba94399b77b85c118706a01
Autor:
Keungmo Yang, Hyun Yang, Chang Wook Kim, Hee Chul Nam, Ji Hoon Kim, Ahlim Lee, U Im Chang, Jin Mo Yang, Hae Lim Lee, Jung Hyun Kwon, Soon Woo Nam, Soon Kyu Lee, Pil Soo Sung, Ji Won Han, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Hee Yeon Kim
Publikováno v:
Gut and Liver, Vol 18, Iss 5, Pp 877-887 (2024)
Background/Aims: Bile duct invasion (BDI) is rarely observed in patients with advanced hepatocellular carcinoma (HCC), leading to hyperbilirubinemia. However, the efficacy of pretreatment biliary drainage for HCC patients with BDI and obstructive jau
Externí odkaz:
https://doaj.org/article/d0a188bfea144c0182c178a539d69230
Autor:
Jaejun Lee, Ahlim Lee, Pil Soo Sung, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Hyun Yang
Publikováno v:
The Korean Journal of Internal Medicine, Vol 39, Iss 4, Pp 577-589 (2024)
Background/Aims Four high-genetic barrier nucleos(t)ide analogues (NAs) for chronic hepatitis B (CHB), namely entecavir (ETV), tenofovir disoproxil fumarate (TDF), tenofovir alafenamide (TAF), and besifovir dipivoxil maleate (BSV), have been establis
Externí odkaz:
https://doaj.org/article/b6bcd490553b4811b0630e834a30a8f1
Autor:
Jung Hoon Cha, Na Ri Park, Sung Woo Cho, Heechul Nam, Hyun Yang, Eun Sun Jung, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung, Si Hyun Bae
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundMetabolic dysfunction-associated steatohepatitis (MASH) is characterized by persistent inflammatory cascades, with macrophage activation playing a pivotal role. Chitinase 1 (CHIT1), produced by activated macrophages, is a key player in this
Externí odkaz:
https://doaj.org/article/46342dc970f84814af40a22447fbbd70
Autor:
Heechul Nam, Jaejun Lee, Ji Won Han, Soon Kyu Lee, Hyun Yang, Hae Lim Lee, Pil Soo Sung, Hee Yeon Kim, Seok-Hwan Kim, Myeong Jun Song, Jung-Hyun Kwon, Chang Wook Kim, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
Publikováno v:
Liver Cancer, Pp 1-13 (2023)
Introduction: Despite the emergence of atezolizumab and bevacizumab (A + B) as standard first-line systemic therapy for unresectable hepatocellular carcinoma (HCC), a comprehensive understanding of the clinical significance of immune-related adverse
Externí odkaz:
https://doaj.org/article/aa5ebb1ab0bb46b69d1bb99950fbf6fd
Autor:
Ji Won Han, Min Woo Kang, Soon Kyu Lee, Hyun Yang, Ji Hoon Kim, Jae-Sung Yoo, Hee Sun Cho, Eun Ji Jang, Deok Hwa Seo, Jung Hyun Kwon, Soon Woo Nam, Si Hyun Bae, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung
Publikováno v:
Liver Cancer, Pp 1-1 (2024)
Introduction: Variability in response to atezolizumab plus bevacizumab (AB) treatment of hepatocellular carcinoma (HCC) underscores the critical need for the development of effective biomarkers. We sought to identify peripheral blood biomarkers refle
Externí odkaz:
https://doaj.org/article/84cd202646194b4e9c57f9794862c15e
Autor:
Han Ah Lee, Sangheun Lee, Hae Lim Lee, Jeong Eun Song, Dong Hyeon Lee, Sojung Han, Ju Hyun Shim, Bo Hyun Kim, Jong Young Choi, Hyunchul Rhim, Do Young Kim
Publikováno v:
Journal of Liver Cancer, Vol 23, Iss 2, Pp 362-376 (2023)
Background/Aim Despite the increasing proportion of elderly patients with hepatocellular carcinoma (HCC) over time, treatment efficacy in this population is not well established. Methods Data collected from the Korean Primary Liver Cancer Registry, a
Externí odkaz:
https://doaj.org/article/28be65f7a5324ee1a0fbd420f76990af